Trial Profile
Efficacy and Safety of Fexinidazole in Patients With Stage 1 or Early Stage 2 Human African Trypanosomiasis (HAT) Due to T.b. Gambiense: a Prospective, Multicentre, Open-label Cohort Study, plug-in to the Pivotal Study
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 25 Jun 2020
Price :
$35
*
At a glance
- Drugs Fexinidazole (Primary)
- Indications Trypanosomiasis
- Focus Therapeutic Use
- 23 Jun 2020 Status changed from active, no longer recruiting to completed.
- 06 Oct 2016 Planned End Date changed from 1 Dec 2015 to 1 Apr 2017.
- 06 Oct 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Oct 2016.